When George Church, PhD, and co-founders established Colossal Biosciences, they envisioned applying their advancements in CRISPR gene editing to the loss of biodiversity, species preservation, and ...
Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...
Newly Created Form Bio Raises $30M Series A Funding Led by JAZZ Venture Partners to empower life scientists with a complete platform for managing large datasets, executing verified workflows, ...
The cell and gene therapy field is, some say, at a tipping point—poised to take off. The FDA has noted that, by next year, they aim to approve 10–20 new cell and gene therapies per year. To do that, ...
Proven technology driven biotech leader to accelerate company's next phase of AI-powered growth in genetic medicine and genome engineering AUSTIN, TX / ACCESS Newswire / August 18, 2025 / Form Bio, a ...
DALLAS, Texas--(BUSINESS WIRE)--Colossal Biosciences, the de-extinction company behind the woolly mammoth and thylacine, today announced the launch of Form Bio, a new independent company offering a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback